PharmExec Picks: Having trouble viewing this e-mail? Click here.

Update My Profile | Advertise With Us | Visit PharmExec.com | PRINT SUBSCRIBE | DIGITAL SUBSCRIBE Pharm Exec Picks is a biweekly eletter that delivers the most popular news and articles from the pharma space and highlights what’s trending on social media. Top 5 Stories : Pharm Exec’s 2015 Emerging Pharma Leaders Slide Show This year’s Pharm Exec list of 17 leaders is ripe with the diversified backgrounds and skills required to advance to the “c-suite” in a new era of change for the industry. Read more Pharm Exec's 2015 Pharma 50 Slide Show Our annual Pharma 50 listing is clear proof that once-small and midsize biopharma companies are moving up to join the top ranks of big Pharma. Read more     Express Scripts 2020: Back to the Future? The clocks are ticking for Express Scripts. Having achieved formidable “size and scale,” how will the nation’s largest pharmacy benefit manager synchronize with value-based health care? With each day, between the medical and pharmacy benefits, the time to value is diverging. Read more So What’s Holding Up a 100 Year-Old Super Bug Killer? According to the Centers for Disease Control (CDC), about 2 million people fall victim to antibiotic resistant infections annually in this country and 23,000 die from those infections.  CDC’s Director has expressed concern that soon there may be no effective treatment for the growing number of antibiotic resistant super bugs. Read more     Epidemiology Arising: A Pharm Exec Roundtable “Value” is the metric that counts in certifying new products for payer reimbursement. But defining that value is a complex, messy, multi-polar task—one that many observers of the process now say should not be left to the cost fixations of academic economists. Read more   Follow Us   Trending on Social Media : Pharma Faces More Comparisons of Drug Costs and Effectiveness Will emerging drug cost assessment initiatives provide useful, valid information on total drug value? Or will new “scores” on drug cost-effectiveness merely justify more no-coverage decisions by insurers and health plans? Read more Will French Reconnection Help Regulatory Convergence in Europe? Fifty years after the first European Union drug regulation was adopted, it may seem odd to speak of Europe still edging towards European regulation in this field. After all, the EU will hold the equivalent of a ceremonial high mass in late September to commemorate that founding piece of legislation, lovingly referred to by devotees of the arcane as Directive 65/65/EEC. Read more What Time is It? Time to Get a Wearable Strategy Launched late in April 2015, Cupertino’s smartwatch made the usual Apple shaped splash in the media. From the minute CEO Tim Cook walked onstage to tell the world it had arrived, the tech and mainstream press went nuts for the newest technology must-have. Read more